Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Amato

Showing results (11-20 of 330) with videos related to

Pageof 33
Sort By:
CNS Drugs|March 17, 2015
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugsMaria Pia Amato, Emilio Portaccio
Nature Reviews. Neurology|January 5, 2023
A first step towards preventive medicine in multiple sclerosisMaria Pia Amato, Emilio Portaccio
Neurology|October 31, 2018
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Maria Pia Amato
Neurology|September 18, 2025
Moving Closer to the Prevention of Cognitive Disability in People With Pediatric-Onset Multiple SclerosisEmilio Portaccio, Maria Pia Amato
Journal of the Neurological Sciences|March 23, 2007
Clinical outcome measures in multiple sclerosisMaria Pia Amato, Emilio Portaccio
The Lancet. Neurology|December 20, 2024
Multiple sclerosis in 2024: evolving evidence and new hopesMaria Pia Amato, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Cognitive impairment in multiple sclerosis: Where do we stand today?Maria Pia Amato, Emilio Portaccio
Nature Reviews. Neurology|February 1, 2018
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
CNS Drugs|June 2, 2009
Improving compliance with interferon-beta therapy in patients with multiple sclerosisEmilio Portaccio, Maria Pia Amato
Expert Opinion on Pharmacotherapy|January 7, 2012
Management options in multiple sclerosis-associated fatigueMaria Pia Amato, Emilio Portaccio
Pageof 33

Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
CNS Drugs|March 17, 2015
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugsMaria Pia Amato, Emilio Portaccio
Nature Reviews. Neurology|January 5, 2023
A first step towards preventive medicine in multiple sclerosisMaria Pia Amato, Emilio Portaccio
Neurology|October 31, 2018
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Maria Pia Amato
Neurology|September 18, 2025
Moving Closer to the Prevention of Cognitive Disability in People With Pediatric-Onset Multiple SclerosisEmilio Portaccio, Maria Pia Amato
Journal of the Neurological Sciences|March 23, 2007
Clinical outcome measures in multiple sclerosisMaria Pia Amato, Emilio Portaccio
The Lancet. Neurology|December 20, 2024
Multiple sclerosis in 2024: evolving evidence and new hopesMaria Pia Amato, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Cognitive impairment in multiple sclerosis: Where do we stand today?Maria Pia Amato, Emilio Portaccio
Nature Reviews. Neurology|February 1, 2018
Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapyMaria Trojano, Maria Pia Amato
CNS Drugs|June 2, 2009
Improving compliance with interferon-beta therapy in patients with multiple sclerosisEmilio Portaccio, Maria Pia Amato
Expert Opinion on Pharmacotherapy|January 7, 2012
Management options in multiple sclerosis-associated fatigueMaria Pia Amato, Emilio Portaccio
Pageof 33